Potent selective inhibitors of protein kinase C

FEBS Letters

Volumn 259, Issue 1, 1989, Pages 61-63

  Davis, Peter D ^a   Hill, Christopher H ^a   Keech, Elizabeth ^a   Lawton, Geoffrey ^a   Nixon, John S ^a   Sedgwick, Anthony D ^a   Wadsworth, Julie ^a   Westmacott, Donald ^a   Wilkinson, Sandra E ^a  

^a ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

Interleukin 2; Platelet; Protein kinase C; Selective inhibition; T cell

Indexed keywords

3,4 BIS(1 METHYL 3 INDOLYL) 2,5 PYRROLEDIONE DERIVATIVE; ENZYME INHIBITOR; INTERLEUKIN 2; K 252A; PROTEIN KINASE C; STAUROSPORINE; STAUROSPORINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME INHIBITION; MICROORGANISM; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE;

ALKALOIDS; ANIMAL; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOOD PLATELETS; BRAIN; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; IMIDES; PROTEIN KINASE C; PROTEIN KINASES; RATS; RECEPTORS, ANTIGEN, T-CELL; STAUROSPORINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0024828113     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(89)81494-2     Document Type: Article

References (17)

1. Multiple kinases and signal transduction. Phosphorylation of the T cell antigen receptor complex.